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http://www.biomedcentral.com/1471-230X/12/165RESEARCH ARTICLE Open AccessGreen tea consumption and risk of esophageal
cancer: a meta-analysis of epidemiologic studies
Ping Zheng1, Hai-ming Zheng2, Xing-ming Deng1* and Yang-de Zhang1*Abstract
Background: Green tea has shown the role of chemoprevention for cancer. Recently, several studies suggested
that green tea intake may have effect on esophageal cancer risk, whereas the results were inconsistent.
Methods: We performed a meta-analysis of all English and Chinese language studies of green tea consumption
and esophageal cancer risk indexed in Medline, Embase, the Science Citation Index, the Chinese Biomedical
Database and Wanfang Data from 1980 to June 2012. After reviewing each study, extracting data, and evaluating
heterogeneity (Chi-square-based Q test and Ι2) and publication bias (Begg and Egger test), a meta-analysis was
performed to evaluate the association between high/medium/low green tea consumption and non-drinking
esophageal cancer risk. Pooled relative risk (RR) or odds ratio (OR) with 95% confidence intervals (CIs) were
calculated using the fixed- or random-effect models.
Results: Ten eligible epidemiologic studies including 33731 participants and 3557 cases for esophageal cancer
were included. Eight of which were case–control studies, and two were cohort studies. Overall, there were no
association between high/medium/low green tea consumption and non-drinking risk of esophageal cancer (High:
highest vs non-drinker: RR/OR = 0.76, 95% CI: 0.49 to 1.02. Medium: drinker vs non-drinker: RR/OR = 0.86, 95% CI:
0.70 to 1.03. Low: lowest vs non-drinker: RR/OR = 0.83, 95% CI: 0.58 to 1.08). When stratified analyses according to
study design (case–control and cohort studies), country (China and Japan), participates source (population-based
and hospital-based case–control), and gender (female and male), there were significant association between
high/medium/low green tea consumption and non-drinking risk of esophageal cancer among female
(High: RR/OR = 0.32, 95% CI: 0.10 to 0.54. Medium: RR/OR = 0.43, 95% CI: 0.21 to 0.66. Low: RR/OR = 0.45,
95% CI: 0.10 to 0.79), but not the others.
Conclusions: We did not found significant association between green tea consumption and non-drinking
esophageal cancer risk, but an evidence of protective effect was observed among female.Background
Esophageal cancer is a major concern in the world, rank-
ing the sixth most common cause of cancer mortality
[1]. Lifestyles such as cigarettes smoking, alcohol drink-
ing and dietary habits have been suggested to be asso-
ciated with the carcinogenesis of esophageal cancer
[2,3]. Tea is one of the most widely consumed beverages
in the world [4]. Tea is divided into three major types:
green tea (non-fermented), oolong tea (half-fermented)
and black tea (fermented) according to on the manufac-
turing process. Green tea and its constituents such as* Correspondence: qqrryyzz@sina.com; zyd99@189.cn
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reproduction in any medium, provided the orepigallocatechin-3 gallate (EGCG), epigallocatechin
(EGC) and epicatechin-3 gallate (ECG) have been shown
to inhibit tumorigenesis in many animal models [5,6].
There have been a number of epidemiologic studies
evaluated the relation between green tea intake and
esophageal cancer risk in human, but with different
results. Two large case–control studies [7,8] showed the
protective effect of green tea intake on esophageal can-
cer incidence. However, another case–control study in-
cluding 883 cases showed that people who have more
consumption of green tea more susceptible to esopha-
geal cancer [9]. No quantitative attempt has been to
summarize the results of studies exploring a possible as-
sociation between green tea and esophageal cancer.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the association in epidemiologic studies.
Methods
Search strategy
The electronic databases, Medline (1966 to June 2012),
Embase (1980 to June 2012), the Science Citation Index
(1945 to June 2012), the Chinese Biomedical Database
(1981 to June 2012) and Wanfang Data (1980 to June
2012) were searched for epidemiologic studies published
in English or Chinese of green tea intake in relation to
esophageal cancer risk. We used the search terms “tea”,
“food”, “diet”, “beverage”, “drinking” or “tea polyphenol”
combined with “esophageal”, “oesophageal”, or “esopha-
gus”. Firstly, the title and abstract of identified relevant
studies were used to exclude any obviously irrelevant
studies. The full-texts and tables of the remaining arti-
cles were retrieved and perused to determine the rele-
vancy of the study design and data, according to the
inclusion criteria detailed below. Additional studies were
identified by screening the reference lists of each rele-
vant study. Furthermore, reviews concerning the rele-
vant topic were retrieved from the above-mentioned
databases in order to potentially broaden the search by
identifying additional relevant publications from the
studies cited in the reviews.
Inclusion criteria
The following inclusion criteria were used to select rele-
vant studies for the meta-analysis: (a) human studies,
not laboratory or animal studies were included; (b) the
daily consumption of the natural green tea product, not
of green tea extracts or supplements were recorded; (c)
the outcome of interest had to be an incidence of
esophageal cancer; (d) relative risk (RR) or odds ratio
(OR) estimates with corresponding 95% CIs (or suffi-
cient information to calculate them) were reported. If
two or more studies used the same population resource
or had overlapping subjects, only the study reporting the
largest population was selected for inclusion in the
meta-analysis.
Data extraction
Two reviewers (Ping Zheng and Haiming Zheng) inde-
pendently performed the data extraction. Disagreements
were resolved by reviewers (Deng and Zhang), and a
consensus was reached for all data prior to meta-ana-
lysis. The following information was collected: the first
author’s name, publication year, the country of origin,
follow-up duration, gender, the number of participants
(cases and cohort size), measurements of green tea con-
sumption, relative risk (RR, which is a ratio of the
exposed group and non-exposed group incidence rate
and suitable for cohort/prospective study), or odds ratioestimates (OR, which is suitable for case–control studies),
and their corresponding 95% confidence intervals (95%
CIs). We treated them as two different studies when a
study provided separate RR/OR estimates for men and
women. If a study provided several RR/ORs, we extracted
the RR/ORs reflecting the greatest degree of control for
potential interaction factors. When a study provided RR/
OR for both esophageal cancer and invasive esophageal
cancer, we used the former due to getting more cases.
Statistical analysis
To evaluate the association between green tea consump-
tion and risk of esophageal cancer, the RR/OR with 95%
CIs were calculated using pooled data from the studies.
Data pooling was carried out by using the fixed effects
model (based on the Mantel-Haenszel method) or the
random effects model (based on the Dersimonian and
Laird method) [10,11] The random effects model was
used if heterogeneity existed between the studies from
which the data was extracted; otherwise, the fixed effects
model was used. Statistical heterogeneity between stud-
ies was assessed with the Chi-square-based Q test and
Ι2, and heterogeneity was considered significant when
the two-tailed P value was less than 0.10 [12]. Ι2 was
used to qualify variation in RR/OR that was attributable
to heterogeneity [13]. Publication bias was estimated by
using the Begg and Mazumdar adjusted rank correlation
test and the Egger regression asymmetry test [14,15].
Finally, the statistical significance of the RR/OR was
determined by using the Z test.
Since the original data of tea consumption dose is non-
linear, we divided the level of consumption into high,
medium and low groups. We calculated the highest/lowest
level of tea consumption as high/low group to compare
with the non-drinking when the original literature pro-
vided the group of tea-drinking dose. When there is no
dose group, we use the drink group as highest/lowest level
of tea consumption respectively. We calculated the drink-
ing of tea consumption as medium group to compare with
the non-drinking when the original literature provided the
group of tea-drinking. And when there is several dose
groups, we use the combination as drink group. So we
generated three group of tea intake: highest vs non-
drinker, drinker vs non-drinker, lowest vs non-drinker.
We performed meta-analysis for all the included stud-
ies, and then made subgroup analysis according to study
design, country, participates source and gender. This
work was conducted on the basis of MOOSE guidelines
proposed by the Meta-Analysis of Observational Studies
in Epidemiology group [16]. All P values are two-tailed.
For all tests, P values < 0.10 are considered statistically
significant, except for heterogeneity. All analysis was
performed by the Stata version 11.0 software (Stata Cor-
poration, College Station, Texas).
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Characteristics of included studies
Ten epidemiologic studies [7-9,17-21] including 33731
participants and 3557 cases of esophageal cancer were
identified according to the inclusion criteria of the meta-
analysis. The characteristics of the included studies areTable 1 Characteristic of including studies of green tea intake
Study Country; design Study
period
Population




1990-1993 902 (male:622, female: 2








1998-1998 68 cases and 68
population- based contr
Mu (2003) Taixing, China
population-based,
case control study























2004-2006 355(male:223, female: 13
cases and 408 (male:252
female: 156) population
controls
Wu (2009) Dafeng China
population based
case control study
2003-2007 637(male:426, female: 21
cases and 1938 (male:13
female: 570) Dafeng
population controls
Wu (2009) Ganyu China population
based case control study
2003-2007 883 (male:765, female: 1















2003-2007 266 cases and 386
population- based contr
OR, odds ratio; RR, relative risk; CI, confidence interval.summarized in Table 1. The publication dates in this
study ranged between 1994 and 2011. Eight of them [7-
9,18-21] were case–control studies (seven conducted in
China and one in Iran), and the other two were cohort
studies (conducted in Japan) [17]. Among eight case–
control studies, seven studies were population-basedand incidence risk of esophageal cancer






Male: drinking vs. never drinking
0.80 (0.58-1.09) 1-199g/month vs.
never drinking 0.79 (0.53-1.17)
>200g/month vs. never drinking
0.79 (0.56-1.13) Female: drinking
vs. never drinking 0.50 (0.30-0.83)
1-199g/month vs. never drinking
0.77 (0.39-1.53) >150g/month vs.
never drinking 0.34 (0.17-0.69)
Age, education, birthplace,
cigarette smoking (both sexes),
and alcohol intake (men only).
ols
drinking vs. never drinking 0.20
(0.06- 0.67)
Age, education, cigarette
smoking, and alcohol intake .
ital <125g/month vs. never drinking
1.13 (0.67-1.92) 125-250g/month
vs. never drinking 0.78 (0.46-1.34)
>250g/month vs. never drinking
0.58 (0.35-0.97)
Age, education, cigarette
smoking, and alcohol intake .
1-2 cups/day vs. < never or
occasionally 0.69(0.17-2.91) 3–4
cups/day vs. < never or
occasionally 1.58(0.52-4.76) 5
cups/day vs. < never or
occasionally 1.78(0.66-4.82)
Age, sex, cigarette smoking,
alcohol consumption,
consumption of black tea,
coffee
1-2 cups/day vs. < never or
occasionally 1.22 (0.47-3.19) 3–4
cups/day vs. < never or
occasionally 0.85 (0.30-2.40) 5
cups/day vs. < never or
occasionally 1.61(0.71-3.66)
Age, sex, cigarette smoking,
alcohol consumption,




Male: drinking vs. never drinking
1.37 (0.95–1.98) Female: drinking
vs. never drinking 0.26 (0.07–0.94)
Age (continuous), , sex, cancer
family history and BMI, marital
status and education years.
smoking , alcohol drinking.
1)
68,
<150g/month vs. never drinking
1.0 (0.7-1.3) 125-250g/month vs.
never drinking 1.0 (0.6-1.8)
>250g/month vs. never drinking
1.0 (0.6–2.0)
Age , gender, education level,
income, cancer family history,




<150g/month vs. never drinking
1.1(0.7-1.7) 125-250g/month vs.
never drinking 1.0 (0.7-1.6)
>250g/month vs. never drinking
1.6 (1.1–2.2)
age , gender, education level,
income, cancer family history,
BMI smoking , alcohol
drinking. tea temperature
ital <100g/month vs. never drinking
1.27(0.72-1.89) 100-250g/month
vs. never drinking 0.97 (0.59-2.56)
>250g/month vs. never
drinking0.92 (0.49-2.32)
age, sex, education level,
annual income, cancer family
history, smoking and drinking
status
ols
Daily, weekly vs Never, <weekly
0.65 (0.32 to 1.31)
ethnicity, daily vegetable intake
alcohol consumption, tobacco
or opium ever use, duration of
residence in rural areas,
Figure 1 Begg’s funnel plot of studies on high green tea intake
and esophageal cancer risk about results of the included
studies. The solid line in the center is the natural logarithm of
pooled relative risk ratio (RR/OR), and two oblique lines are pseudo
95% confidence limits. SE, standard error.
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was hospital-based case–control (HCC) [19]. In addition,
there were two studies [7,18] provided gender-specific
OR estimates and 95% CIs for the association between
green tea consumption and esophageal cancer risk.Figure 2 Forest plot: Results of the studies on high green tea intake.
the study in the meta-analysis. The combined relative risk is calculated usinMeta-Analysis of categories of consumption
Three categories of consumption have been generated:
high (Figure 1, Figure 2, Table 2), medium (Figure 3,
Figure 4, Table 3), low (Figure 5, Figure 6, Table 4).
Meta-Analysis of Case–control studies
Eight case–control studies were included. Of which, two
studies [7,18] presented the OR and CIs for female and
male respectively, and one study for participates from
two different areas. All of them were treated as two
studies when analysed.
In the meta-analysis, green tea consumption was
found to be associated with a significantly lower risk of
esophageal cancer in high group (RR/OR = 0.72, 95% CI:
0.45 to 0.98, Table 2). The P value of heterogeneity
chi-squared test was < 0.01, and the corresponding I2
statistic was 76%, suggesting variability between studies.
The P values for the Begg’s and the Egger’s tests were
P = 0.07 and P = 0.02, respectively, suggesting the
probability of publication bias.
The results in Medium and low group were not statis-
tically significant (respectively: RR/OR = 0.85, 95% CI:
0.67 to 1.02, Table 3. RR/OR = 0.82, 95% CI: 0.56 to
1.09, Table 4). The P value of heterogeneity chi-squaredThe size of the data markers (squares) corresponds to the weight of
g the random effects method.













Overall 10 3557 0.76(0.49-1.02) 0.00 0.73 0.37 0.16
Country
Japan 2 78 1.67(0.46-2.87) 0.90 0.00 1.00 NA
China 7 3213 0.73(0.44-1.02) 0.00 0.79 0.12 0.05
Northern Iran 1 266 0.65 (0.32-1.31) NA NA NA NA
Study design
Cohort studies 2 78 1.67(0.46-2.87) 0.90 0.00 1.00 NA
Case control 8 3479 0.72(0.45-0.98) 0.00 0.76 0.07 0.02
Participates source
PCC 7 3329 0.71 (0.43-0.98) 0.00 0.78 0.05 0.02
HCC 1 150 0.92 (0.49-2.32) NA NA NA NA
Gender
Male 2 845 1.04(0.48-1.60) 0.05 0.73 1.00 NA
Female 2 412 0.32(0.10-0.54) 0.75 0.00 1.00 NA
NA; not applicable; PCC: population based case control; HCC: hospital based case control.
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65%, 72%. The P value for the Begg’s test and Egger’s test
were 0.03 and 0.02, 0.07 and 0.01, respectively.Meta-Analysis of Cohort studies
Two cohort studies were included [17]. The association
between green tea consumption and the risk of esopha-
geal cancer were all not statistically significant (high/
medium/low respectively: RR/OR = 1.67, 95% CI: 0.46 to
2.87, Table 2. RR/OR = 1.14, 95% CI: 0.46 to 2.87,
Table 3. RR/OR = 0.96, 95% CI: 0.01 to 1.92, Table 4).Figure 3 Begg’s funnel plot of studies on medium green tea
intake and esophageal cancer risk about results of the included
studies. The solid line in the center is the natural logarithm of
pooled relative risk ratio (RR/OR), and two oblique lines are pseudo
95% confidence limits. SE, standard error.The P value of heterogeneity chi-squared test were
0.90, 0.90 and 0.59, respectively. The corresponding I2
statistic were all 0.0%, indicating a low variability be-
tween studies. The P value for the Begg’s test and Egger’s
test were 1.00 and not applicable, 0.26 and 0.17, 0.07
and 0.01, respectively.
Combined and Subgroup Analysis
Furthermore, we performed the combined analysis of
case–control and cohort studies. The association be-
tween green tea consumption and non-drinking risk of
esophageal cancer were not statistically significant in
three group (High: RR/OR = 0.76, 95% CI: 0.49 to
1.02, Table 2. Medium: RR/OR = 0.86, 95% CI: 0.70 to
1.03, Table 3. Low: RR/OR = 0.83, 95% CI: 0.58 to 1.08,
Table 4.). The P value of heterogeneity chi-squared test
were all < 0.01. The corresponding I2 statistic were 73%,
56%, 66%, respectively. The P value for the Begg’s test
and Egger’s test were 0.37 and 0.16, 0.24 and 0.22, 0.16
and 0.03, respectively. Overall, no association was found
between green tea consumption and non-drinking risk
of esophageal cancer.
When stratified by country, we did not found associ-
ation between green tea consumption and non-drinking
risk of esophageal cancer in China, Japan and Northern
Iran (Tables 2, 3, 4).
When stratified by participates source, we found a sig-
nificant association between high green tea consumption
and non-drinking esophageal cancer risk among PCC
(RR/OR = 0.71; 95% CI: 0.43-0.98, P < 0.01 for hetero-
geneity, I2 = 78%), but not the HCC (RR/OR = 0.92; 95%
Figure 4 Forest plot: Results of the studies on medium green tea intake. The size of the data markers (squares) corresponds to the weight
of the study in the meta-analysis. The combined relative risk is calculated using the random effects method.
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found association between medium/low green tea con-
sumption and non-drinking risk of esophageal cancer in
PCC and HCC.
There were two studies [7,18] provided gender-specific
RR estimates and 95% CIs for the association between
green tea consumption and esophageal cancer risk,
therefore we also made stratified analysis by gender. The
results of meta-analysis showed that there were signifi-
cant association between high/medium/low green tea
consumption and non-drinking risk of esophageal can-
cer among female (High: RR/OR = 0.32, 95% CI: 0.10
to 0.54, P = 0.75 for heterogeneity, Table 2. Medium:
RR/OR = 0.43, 95% CI: 0.21 to 0.66, P = 0.35 for het-
erogeneity, Table 3. Low: RR/OR = 0.45, 95% CI: 0.10
to 0.79, P = 0.16 for heterogeneity, Table 4), but not
the male.Sensitivity analysis
Sensitivity analysis has been carried out by excluding
one study from others step by step in each group. They
did not alter the original results.
Discussion
Our meta-analysis of epidemiologic studies did not
found significant association between high/medium/low
green tea consumption and non-drinking esophageal
cancer risk, while an evidence of protective effect was
observed among female.
However, there are only two cases of case–control in
female studies which existed all in China, this result can
lead to selection bias. In addition, the positive results are
more easily published, making publication bias gener-
ated. All that makes worthy of further consideration
about female results. If excluding these factors, some







RR or OR (95%
CI)
Heterogeneity Publication bias
p I2 Begg’s test Egger’s test
Overall 10 3557 0.86(0.70-1.03) 0.00 0.56 0.24 0.22
Country
Japan 2 78 1.14(0.46-2.87) 0.90 0.00 0.26 0.17
China 7 3213 0.86 (0.67-1.05) 0.00 0.67 0.04 0.03
Northern Iran 1 266 0.65 (0.32-1.31) NA NA NA NA
Study design
Cohort studies 2 78 1.14(0.46-2.87) 0.90 0.00 0.26 0.17
Case control 8 3479 0.85(0.67-1.02) 0.00 0.65 0.03 0.02
Participates source
PCC 7 3329 0.82(0.63-1.01) 0.00 0.69 0.03 0.01
HCC 1 150 1.13(0.69-1.57) 0.77 0.00 0.30 0.01
Gender
Male 2 845 1.04(0.49-1.59) 0.05 0.74 1.00 NA
Female 2 412 0.43(0.21-0.66) 0.35 0.00 1.00 NA
NA; not applicable; PCC: population based case control; HCC: hospital based case control.
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female.
Sex hormone may be an explanation for why female
experiencing significantly a lower risk of esophageal
cancer when take high level green tea. A sex hormone-
mediated pathway may be involved in esophageal car-
cinogenesis, which was supported by two experimental
studies [22,23]. A suppressing effect of estrogen and a
promoting effect of androgen were shown in the experi-
mental induction of esophageal cancer by the adminis-
tration of chemical carcinogen [22]. Meanwhile, the
growth rate of metastatic squamous cell carcinoma ofFigure 5 Begg’s funnel plot of studies on low green tea intake
and esophageal cancer risk about results of the included
studies. The solid line in the center is the natural logarithm of
pooled relative risk ratio (RR/OR), and two oblique lines are pseudo
95% confidence limits. SE, standard error.the esophagus was inhibited by estrogen and enhanced
by testosterone, respectively [23]. Additional studies
are warranted to explain and confirm this preliminary
evidence.
There have been a number of experimental and clin-
ical studies suggesting drinking beverages at high tem-
peratures to be a cause of esophageal cancer. The facts
that more tumors were showed and larger size of
esophagus papillomas were rapidly increased when the
temperature at 70°C and above was reported by a previ-
ous experimental study [24]. In our meta-analysis, two
included studies [9,19] both found that drinking tea at
high temperature significantly increases risk of esopha-
geal cancer incidence. However, the two studies had dif-
ferent definition for high or normal temperature of
green tea drinking, which make it difficult to be strati-
fied for further analysis.
Three studies [9,17,19] included in the meta-analysis
have investigated the effects of green tea drinking and
dose response relationship. No dose–response relation-
ship was observed among the two studies [17,19]. In the
study conducted by Wu [9], higher monthly consump-
tion of tea (P for trend = 0.07) and usually drinking tea
in high concentration (P for trend = 0.01) showed a
positive tendency with cancer risk for ever drinker after
adjusting for tea temperature. We have analysised data
by grouping high/medium/low intake. However, we have
not found it is effective between green tea consumption
and non-drinking in esophageal cancer risk.
The protective effect of high green tea consumption
on esophageal cancer was observed among case–control
Figure 6 Forest plot: Results of the studies on low green tea intake. The size of the data markers (squares) corresponds to the weight of the
study in the meta-analysis. The combined relative risk is calculated using the random effects method.













Overall 10 3557 0.83(0.58-1.08) 0.00 0.66 0.12 0.03
Country
Japan 2 78 0.96(0.01-1.92) 0.59 0.00 1.00 NA
China 7 3213 0.85(0.56-1.13) 0.00 0.75 0.18 0.03
Northern Iran 1 266 0.65 (0.32-1.31) NA NA NA NA
Study design
Cohort studies 2 78 0.96 (0.01-1.92) 0.59 0.00 1.00 NA
Case control 8 3479 0.82 (0.56-1.09) 0.00 0.72 0.07 0.01
Participates source
PCC 7 3329 0.78(0.51-1.05) 0.00 0.73 0.03 0.01
HCC 1 150 1.27(0.72-1.89) NA NA NA NA
Gender
Male 2 845 1.04(0.48-1.61) 0.06 0.72 1.00 NA
Female 2 412 0.45(0.10-0.79) 0.16 0.49 1.00 NA
NA; not applicable; PCC: population based case control; HCC: hospital based case control.
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lication bias are significant. So the protective effect
among case–control studies and PCC may be incredible.
Furthermore we performed the combined analysis of
case–control and cohort studies. The heterogeneity and
publication bias are not significant in the overall study.
So, there may be no significant association between high
green tea consumption and non-drinking esophageal
cancer risk in the meta-analysis.
Focus on heterogeneity and publication bias of the
analyses, we found all the estimates with several studies
with a large sample size are very heterogeneous, while
estimates with a couple of studies and small sample size
have no heterogeneity. For example, both meta-analyses
of all studies (ten studies) and case–control studies
(eight studies), the P for heterogeneity were < 0.01,
suggesting variability between studies. However, for
meta-analyses among female (two studies) or male (two
studies), the P for heterogeneity were both > 0.05, sug-
gesting a low variability between studies. When hetero-
geneity existed we used the random effects model to
adjusted. The publication bias among case–control and
PCC studies are significant in high group. The cautions
for above phenomenon may be as follows: (a) Most of
case–control and population-based case–control studies
were performed among China [7-9,18-21], and that may
cause bias. (b) Retrospective bias. (c) Positive results
may be publicated more easily. Furthermore, we per-
formed subgroup analysis by sex, geographic region and
type of epidemiologic studies.
However, there are several disadvantages should be
considered in our meta-analysis. First, publication bias
in China studies or case control studies cannot be
missed. The protective effect of green tea in female may
be misled by a publication bias because of the female
studies all from China studies or case control studies.
Second, the epidemiologic studies were not much
enough to be stratified for dose and temperature of
green tea intake, which may mitigate the result. Third,
the non-English and non-Chinese literature could not be
reviewed because of the language barrier. Last, most of
the studies included in the analysis had been conducted
among Asian populations due to popularity of green tea
in East Asia. Therefore, the results should be cautious
extrapolated to other populations.
Conclusions
The results of our meta-analysis did not found signifi-
cant association between green tea consumption and
non-drinking esophageal cancer risk, but an evidence of
protective effect was observed among female. Additional
more studies (especial the cohort studies, and studies
from more countries) with careful control of interaction
factors including dose and temperature of green teaintake are needed to provide a more definitive conclu-
sion focusing on whether the routine consumption of
green tea can guard against esophageal cancer.
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